SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is drawing significant attention as traders speculate on potential price rebounds and aggressive short squeezes despite ongoing concerns over market manipulation and delisting rumors. The community remains deeply divided, with some actively loading positions while others warn of a potential pump-and-dump cycle.

Jabil, Inc. engages in the provision of manufacturing services and solutions. It operates through the Electronics Manufacturing Services (EMS) and Diversified Manufacturing Services (DMS) segments. The EMS segment focuses on leveraging information technology, supply chain design and engineering, technologies largely centered on core electronics, utilizing a large-scale manufacturing infrastructure, and the ability to serve a broad range of end markets. The DMS segment offers engineering solutions with an emphasis on material sciences, machining, tooling, and molding of engineered plastic and metal parts. The company was founded by William E. Morean and James Golden in 1966 and is headquartered in St. Petersburg, FL.

Jabil Inc

Jabil is seeing heightened investor attention as earnings reports consistently outperform analyst expectations, driven by surging demand for AI-focused data center infrastructure and cloud hardware. The community remains focused on the company's strategic expansion into U.S.-based manufacturing and long-term potential in AI-integrated hardware, often discussing its resilience and growth narrative against broader market volatility.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is facing sharp market pressure after capping investor withdrawals from its HPS Corporate Lending Fund for the first time due to record redemption requests exceeding the 5% quarterly limit. The move has fueled community concerns regarding liquidity and transparency within the private credit sector, leading to significant downward pressure on the stock.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

Binance and its native token are trending as the platform faces renewed institutional scrutiny regarding historical transaction flows, while simultaneously navigating complex legal victories and ecosystem-wide efforts to integrate AI agents. Community sentiment remains polarized, with active debates centered on the long-term utility of the BNB Chain, the platform's ability to maintain dominance amid regulatory hurdles, and speculative interest in emerging reward tokens.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending as investors discuss the potential for the upcoming reverse merger with Agility Robotics and the resulting ticker change to AGLT. The community is actively debating the project's viability as a pure-play robotics investment, with proponents highlighting strategic support from industry leaders while skeptics raise concerns regarding sales performance and valuation.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is currently trending as investors focus on the upcoming Schedule III administrative hearing, which is viewed as a pivotal step in the sector's regulatory progression. Community discourse remains heavily centered on potential federal banking reform and the expectation that institutional capital will rotate into major U.S. operators following recent moves toward rescheduling.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is drawing intense community attention as retail traders speculate on its meme-driven volatility, with many users highlighting significant cross-holding overlap between its whales and other niche meme projects like Updog. While some participants are actively accumulating during price fluctuations, others remain deeply skeptical of the asset's long-term utility, fueling a polarized debate regarding its potential to sustain momentum or return to zero.

Fidelity Wise Origin Bitcoin Fund - Fidelity Wise Origin Bitcoin Fund Beneficial Interest

Fidelity Wise Origin Bitcoin Fund

The Fidelity Wise Origin Bitcoin Fund is currently at the center of intense debate, as community members weigh whether the recent price volatility represents a necessary correction or the beginning of a prolonged 'crypto winter.' While some investors are aggressively buying the dip, citing long-term institutional adoption and potential regulatory tailwinds, others remain skeptical, warning of technical breakdowns and significant downside risks if key support levels fail.

Re is an internet-native marketplace for insurance capital. It connects eligible capital providers with fully collateralized reinsurance activity conducted through licensed insurance entities. Blockchain infrastructure makes collateral, reserves, and selected operating data verifiable onchain. RE is the governance token of the Re Protocol. It governs protocol upgrades, technical permissions, committee formation, reporting standards, incentive policy, and governance procedures. Underwriting, claims, pricing, reserve decisions, and regulated operations remain with qualified professionals and licensed entities.

RE is capturing investor interest as a decentralized infrastructure project focusing on the insurance sector, with community members actively discussing its recent listings on major trading platforms and its potential as a real-world asset (RWA) play. While some investors are highlighting its unique utility and institutional backing, the community remains divided between those viewing the rapid price movement as a long-term opportunity and others cautioning against high volatility and speculative hype.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is experiencing heightened volatility and community debate as investors navigate conflicting sentiment over its long-term potential compared to newer meme coins and broader crypto market trends. Discussions are dominated by speculation regarding potential integration into X, frustration over stagnant price action, and a persistent divide between believers who are loading up on dips and critics dismissing the asset as a historical pump-and-dump scheme.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone?

Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone...

Rocket PharmaceuticalsAnnounces Closing of Sale ofRare Pediatric Disease Priority Review Voucher for $180 Million

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV...

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the Jefferies Global Healthcare Conference and...

Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where's the Stock Going?

Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where's the Stock Going...

RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus

Rocket Pharmaceuticals shares fell after a wider-than-expected Q1 loss as the company focuses on the launch of newly approved gene therapy Kresladi.

Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need...

Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced a strengthened financial position following the sale of its Rare Pediatric Disease...

Lifesci Capital Has Pessimistic Outlook of RCKT Q1 Earnings

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Lifesci Capital cut their Q1 2026 EPS estimates for shares of Rocket Pharmaceuticals in a research report issued on Thursday, April 16th...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Recommendation of "Hold" by Brokerages

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) has received a consensus rating of "Hold" from the eighteen ratings firms that are presently covering the stock, Marketbeat Ratings...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Short Interest Update

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) was the target of a large increase in short interest in March. As of March 31st, there was short interest totaling 18,580,923 shares, an increase of 26.5% from the March 15th total of 14,693,507 shares. Currently, 22.6% of the company's...

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.

Rocket Pharmaceuticals Inc

RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.25
Prev Close	$3.24
Open	$3.24
Dividend Yield	0.00%
50-Day Moving Average	$3.28
Beta	1.16
Avg. Volume	2.22M
PE Ratio	-1.73

52-Week High	$5.45
52-Week Low	$2.40
Market Capitalization	$354.88M
EPS (Annual)	-$2.01
Price to Book	1.49
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

RCKTRocket Pharmaceuticals Inc

Latest RCKT News